Dokkyo Medical University, Saitama Medical Center

Saitama 343-8555

0 studies enrolling now · 5 studies all time

What they study most

IgA Nephropathy, Immunoglobulin A Nephropathy, Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Spinal Muscular Atrophy (SMA), Ventricular Tachycardia (VT)

Studies at this site

• Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
• Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial — Completed